Literature DB >> 16484744

Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid.

Junko Takagi1, Kazuo Otake, Munehiko Morishita, Harumichi Kato, Naoki Nakao, Kazuhiro Yoshikawa, Hiroshi Ikeda, Yoshifumi Hirooka, Yoshinobu Hattori, Catharina Larsson, Tsuyoshi Nogimori.   

Abstract

Thymic carcinoid in multiple endocrine neoplasia type 1 (MEN 1) is previously reported as a non-ACTH producing tumor. The present case is a 39-year-old man with mortal outcome from thymic carcinoid and Cushing's syndrome with high plasma ACTH. The symptom was first observed at age 29 and was relieved after extended thymectomy, with reduction of ACTH level. The tumor was positive for ACTH, Grimelius silver staining and Chromogranin A. The finding of primary hyperparathyroidism, pituitary adenoma, and a novel germline nonsense mutation (W423X) established the diagnosis of MEN 1. Cushing's syndrome due to ACTH producing thymic carcinoid should be also considered as one phenotype of the MEN 1 spectrum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484744     DOI: 10.2169/internalmedicine.45.1427

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years.

Authors:  Nicola M Neary; Ariel Lopez-Chavez; Brent S Abel; Alison M Boyce; Nicholas Schaub; King Kwong; Constantine A Stratakis; Cesar A Moran; Giuseppe Giaccone; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

2.  Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred.

Authors:  Xiaohua Li; Jing Su; Li Zhao; Jingcheng Wu; Xiaoying Ding; Fang Fang; Yijie Wu; Haiyan Sun; Yongde Peng
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

3.  Cushing's syndrome in multiple endocrine neoplasia type 1.

Authors:  William F Simonds; Sarah Varghese; Stephen J Marx; Lynnette K Nieman
Journal:  Clin Endocrinol (Oxf)       Date:  2012-03       Impact factor: 3.478

4.  Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation.

Authors:  Shirin Hasani-Ranjbar; Masoud Rahmanian; Azadeh Ebrahim-Habibi; Akbar Soltani; Akbar Soltanzade; Elnaz Mahrampour; Mahsa M Amoli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 5.  Endocrine neoplasms in familial syndromes of hyperparathyroidism.

Authors:  Yulong Li; William F Simonds
Journal:  Endocr Relat Cancer       Date:  2016-05-20       Impact factor: 5.678

Review 6.  Carcinoid tumor of the thymus associated with Cushing's syndrome and dysgeusia: case report and review of the literature.

Authors:  Cristina Claret; Juan J Chillarón; Juana A Flores; David Benaiges; Rafael Aguiló; Mar García; Guadalupe Aguilar; Alberto Goday; Juan F Cano-Pérez
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

Review 7.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

8.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

9.  Evaluation of the prognostic value of surgery and postoperative radiotherapy for patients with thymic neuroendocrine tumors: A propensity-matched study based on the SEER database.

Authors:  Junmiao Wen; Jiayan Chen; Donglai Chen; Di Liu; Xinyan Xu; Lv Huang; Jianzhao Cao; Junhua Zhang; Yu Gu; Min Fan; Yongbing Chen
Journal:  Thorac Cancer       Date:  2018-10-01       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.